Results 61 to 70 of about 16,072 (215)
Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for visceral leishmaniasis (VL), but its clinical efficacy is limited in cutaneous leishmaniasis (CL) and HIV/VL co-infection.
Guilherme S. Ramos +11 more
doaj +1 more source
Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp +6 more
wiley +1 more source
The Effect of Designed Home Visit Program on Promoting Cutaneous Leishmaniasis Preventive Behaviors
Introduction & Aim: Cutaneous Leishmaniasis is the second common parasitic disease in Iran. According to several studies, insufficient knowledge of mothers about the prevention strategies related to occurrence of the disease in their children are ...
A. Hossein nejad Nayrisi +3 more
doaj
Cutaneous leishmaniasis exhibits a wide spectrum of clinical manifestations; however, only a limited number of drugs are available and include Glucantime® and amphotericin B, which induce unacceptable side effects in patients, limiting their use.
Sarah Kymberly Santos de Lima +11 more
doaj +1 more source
Seroepidemiology and molecular diversity of Leishmania donovani complex in Georgia [PDF]
Background Leishmaniasis includes multiple clinical syndromes, most notably visceral, cutaneous, and mucosal forms. Visceral leishmaniasis (VL), also known as kala-azar, is a potentially fatal disease endemic to large parts of Africa and Asia, and in ...
Adeishvili, Ekaterine +15 more
core +3 more sources
Targeting Kinetoplastid Parasites with ProTide Prodrugs: A Proof‐of‐Concept Study
Neglected tropical diseases (NTDs) remain a major global health challenge, particularly in low‐ and middle‐income countries. Kinetoplastid parasites causing Chagas disease, leishmaniasis, and African trypanosomiasis rely on host purine salvage pathways, making nucleoside analogues attractive therapeutic candidates.
Silvester Lowe +6 more
wiley +1 more source
Natural killer cells in experimental and human leishmaniasis
Infections with parasites of the genus Leishmania lead to a rapid, but transient activation of natural killer (NK) cells. In mice activation of NK cells requires a toll-like-receptor 9-dependent stimulation of dendritic cells followed by the production ...
Christian eBogdan
doaj +1 more source
Tongue Sarcoidosis: A Rare Case Report and Review of the Literature
ABSTRACT This study presents a case report with a literature review describing a rare manifestation of oral sarcoidosis involving the tongue in a 57‐year‐old woman with a prior diagnosis of cutaneous sarcoidosis. The lesion appeared as painless grayish‐white papules on the tip and dorsal surface of the tongue.
Saede Atarbashi‐Moghadam +4 more
wiley +1 more source
Enhanced Detection of Leishmania Parasites in Microscopic Images Using Machine Learning Models
Cutaneous leishmaniasis is a parasitic disease that poses significant diagnostic challenges due to the variability of results and reliance on operator expertise.
Michael Contreras-Ramírez +4 more
doaj +1 more source
Leishmaniasis is a disease caused by an intracellular protozoan parasite of the genus Leishmania. Current treatments for leishmaniasis are long, toxic, and expensive and are not available in some endemic regions.
María Angélica Burgos-Reyes +5 more
doaj +1 more source

